
Environmental Encyclopedia 3
Vector (Mosquito) Control
quito control are emptying dishes or birdbaths where water
collects, keeping grass mowed and bushes trimmed, and
filling in low-lying areas so that water is not left to stag-
nate there.
Even with global vector control, malaria is reemerging
in most countries where the disease is endemic. Malaria is
caused by any of four species of protozoan parasites. Plasmo-
dium falciuparum and Plasmodium vivax are the most deadly.
The parasite is transmitted by a particular genus of mosquito,
Anopheles. For many years, malaria was a problem in the
United States. In the 1940s, a massive malaria vector control
program was initiated that used immense quantities of the
potent
pesticide
, DDT, to kill the mosquitoes that transmit
malaria. DDT is an effective agent in the control of mosquito
vectors of disease, but two problems have plagued its use.
The first is its persistence in the
environment
and harmful
effect on fish and
wildlife
and its implication as a mamma-
lian
neurotoxin
that could potentially affect human beings.
The second concern is the emergence of DDT-resistant
strains of mosquitoes. Despite this, DDT is still used in
many underdeveloped areas of the world to control mosquito
infestations that pose a threat to human health and wellbe-
ing. In the United States, the Centers for Disease Control
(CDC) monitors and surveys for malaria and other vector-
borne diseases that endanger the population. The CDC also
advises U.S. citizens on appropriate drug therapies to utilize
while visiting countries where disease-bearing vector species
of mosquitoes are prevalent. In the year 2000, 246 cases of
imported malaria were reported to the CDC.
One effort to control vector spread of malaria has been
the Roll Back Malaria initiative which seeks to reduce the
world’s malaria burden by one half by the year 2010. One
aspect has been the distribution of insecticide-treated mos-
quito nets in areas where malaria vectors are especially prob-
lematic for pregnant women and children, such as the coun-
try Nairobi. As part of the effort, 60,000 insecticide-treated
mosquito nets were distributed in 2002 in cooperation with
the United Nations Children’s Fund. This form of vector
control incorporates physical barriers with chemical insecti-
cides and social education programs to effect change in the
prevalence of this devastating disease.
Mosquito control, however, involves many diseases
other than malaria, however. Dengue fever is a viral infection
transmitted by mosquito vectors that causes paroxysmal joint
and muscle pain, headache, vomiting, and rash. Commonly,
because of its symptoms, Dengue fever is confused with
malaria or typhoid fever, a bacterial infection. Dengue fever
is a potential threat in Africa, China, Southeast Asia, the
Middle East, Central and South America and the Caribbean.
A historically notorious arbovirus, Dengue fever is returning.
According to the CDC Division of Vector-Borne Infectious
Disease, 1997 was the year in which Dengue fever was
1455
the most important mosquito-borne viral disease affecting
humans. At that time, an estimated 2.5 billion people lived
in areas of risk, making Dengue fever a mosquito (vector)
control problem en par with malaria. Four major reasons
for the emergence of Dengue fever as an important mos-
quito-borne disease have been identified. First, sufficient
mosquito control efforts are practically absent in areas where
the risk of contracting Dengue fever is most acute. Second,
uncontrolled population expansion in such areas has led to
a deficit in effective sewer and
waste management
systems,
the result of which only contributes o the spread of vector-
borne disease. Demographic changes leading to inadequate
water management systems have exacerbated this problem.
Thirdly, accessible and rapid
transportation
via airplanes
had created a new, swift means for spread of the Dengue
vector mosquito. Stowaway infected mosquitoes spread dis-
ease to new areas with newfound speed. Finally, limited
financial resources have forced nations challenged by such
vector-borne disease to choose between effective vector con-
trol and other, greatly needed endeavors. Until and unless
Dengue and other vector-borne diseases are recognized as
threats, funding for vector control programs may remain
secondary to more pressing social dilemmas in undeveloped
nations. While no Dengue vaccine exists, vigorous research
employing
biotechnology
continues.
More recently, mosquito-borne illnesses have been
witnessed in North America. West Nile virus has surfaced
in America, formerly only attributed to central Asia, Europe,
Africa, and the Middle East. By 2001, the West Nile virus
had been documented by the CDC to be present in Alabama,
Arkansas, Connecticut, Delaware, Florida, Georgia, Illinois,
Indiana, Iowa, Kentucky, New York, Ohio, Pennsylvania,
Wisconsin, and other mid-Atlantic states. As of 2001, 149
cases of West Nile virus illnesses had been reported to the
CDC, which includes 18 deaths. The West Nile virus is
a variety of
pathogen
called a flavovirus that can cause
encephalitis, coma, and death.
Two additional arbovirus pathogens transmitted by
mosquito vectors in the United States are LaCrosse Enceph-
alitis and Eastern Equine Encephalitis. The LaCrosse virus
belongs top the Bunyviridae subgroup and has approximately
70 cases of infection in the United States annually. While
fatality rate of infection with LaCrosse is less than 1%,
hospitalization and neurological complications that occur
with infection are serious. Children under the age of 16
years are particularly at risk of contracting LaCrosse Enceph-
alitis in endemic areas. A similar vector-borne disease is
Eastern Equine Encephalitis (EEE). The manifestations of
EEE range from influenza-like symptoms to severe swelling
of central nervous tissue, coma, and death. The etiologic
agent for EEE is a family of mosquito-borne viruses called